Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries

Abstract

The aim of this study was to evaluate and compare the effectiveness of N-acetylcysteine (NAC) and liposomally-encapsulated NAC (L-NAC) in ameliorating the hepatotoxic effects of lipopolysaccharide (LPS). LPS, a major cell wall molecule of Gram-negative bacteria and the principal initiator of septic shock, causes liver injury in vivo that is dependent on neutrophils, platelets, and several inflammatory mediators, including tumour necrosis factor-α (TNF-α). Male Sprague-Dawley rats were pretreated intravenously with saline, plain liposomes (dipalmitoylphosphatidylcholine [DPPC]), NAC (25 mg/kg body weight), or L-NAC (25 mg/kg NAC body weight) and 4 h later were challenged intravenously with LPS (Escherichia coli O111:B4, 1.0 mg/kg body weight); animals were killed 20 h post-LPS challenge. Hepatic cell injury was evaluated by measuring the alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities in plasma. LPS-induced activation of the inflammatory response was evaluated by measuring the levels of myeloperoxidase activity and chloramine concentration in liver homogenates as well as TNF-α levels in plasma. The hepatic levels of lipid peroxidation products and non-protein thiols (NPSH) were used to assess the extent of involvement of oxidative stress mechanisms. In general, challenge of animals with LPS resulted in hepatic injuries, activation of the inflammatory response, decreases in NPSH levels and increases in the levels of lipid peroxidation products (malondialdehyde and 4-hydroxyalkenals). Pretreatment of animals with NAC or empty liposomes did not have any significant protective effect against LPS-induced hepatotoxicity. On the other hand, pretreatment of animals with an equivalent dose of L-NAC conferred protection against the liver injuries induced following LPS challenge. These data suggest that NAC when delivered as a liposomal formulation is a potentially more effective prophylactic pharmacological agent in alleviating LPS-induced liver injuries.

Keywords

N-Acetylcysteine liposomes lipopolysaccharide oxidative stress inflammation liver

References

Sakaguchi S. , Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia . FEMS Immunol Med Microbiol 2006; 47: 167—177.

Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med 2007; 22: 63—72.

Jirillo E. , Caccavo D. , Magrone T. et al. The role of the liver in the response to LPS: experimental and clinical findings. J Endotoxin Res 2002; 8: 319—327.

Moran AP Lipopolysaccharide in bacterial chronic infection: insights from Helicobacter pylori lipopolysaccharide and lipid A. Int J Med Microbiol 2007; 297: 307—319.

Hodgson JC Endotoxin and mammalian host responses during experimental disease. J Comp Pathol 2006; 135: 157—175.

Hsu BG , Lee RP , Yang FL , Harn HJ , Chen HI Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sci 2006; 79: 2010—2016.

Roberts RA , Ganey PE , Ju C. , Kamendulis LM , Rusyn I. , Klaunig JE Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis . Toxicol Sci 2007; 96: 2—15.

Kaur G. , Tirkey N. , Chopra K. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity . Toxicology 2006; 226: 152—160.

Li G. , Liu Y. , Tzeng NS et al. Protective effect of dextromethorphan against endotoxic shock in mice. Biochem Pharmacol 2005; 69: 233—240.

10.

Karihtala P. , Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Apmis 2007; 115: 81—103.

11.

Thakur V. , Pritchard MT , McMullen MR , Wang Q. , Nagy LE Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006; 79: 1348—1356.

12.

Tukov FF , Maddox JF , Amacher DE , Bobrowski WF , Roth RA , Ganey PE Modeling inflammation-drug interactions in vitro: a rat Kupffer cell-hepatocyte coculture system. Toxicol In Vitro 2006; 20: 1488—1499.

13.

Cerecetto H. , Lopez GV Antioxidants derived from vitamin E: an overview . Mini Rev Med Chem 2007; 7: 315—338.

14.

Mishra V. Oxidative stress and role of antioxidant supplementation in critical illness . Clin Lab 2007; 53: 199—209.

15.

Victor VM , Rocha M. , Esplugues JV , De la Fuente M.

Role of free radicals in sepsis: antioxidant therapy

Curr Pharm Des 2005; 11: 3141—3158.

16.

Fan J. , Shek PN , Suntres ZE , Li YH , Oreopoulos GD , Rotstein OD Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 2000; 128: 332—338.

17.

Fang JY , Hwang TL , Huang YL , Fang CL Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006; 310: 131—138.

18.

Gortzi O. , Lalas S. , Chinou I. , Tsaknis J. Reevaluation of antimicrobial and antioxidant activity of Thymus spp. extracts before and after encapsulation in liposomes. J Food Prot 2006; 69: 2998—3005.

19.

Padamwar MN , Pokharkar VB Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability . Int J Pharm 2006; 320: 37—44.

20.

Sarkar S. , Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech Ageing Dev 2006; 127: 391—397.

21.

Suntres ZE Role of antioxidants in paraquat toxicity. Toxicology 2002; 180: 65—77.

22.

Wasserman V. , Kizelsztein P. , Garbuzenko O. et al. The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release. Langmuir 2007; 23: 1937—1947.

23.

Allison SD Liposomal drug delivery. J Infus Nurs 2007 ; 30: 89—95; quiz 120.

24.

Suntres ZE , Omri A. The role of liposomal antioxidants in oxidative stress. Berlin: Springer, 2006.

25.

Adrian JE , Kamps JA , Poelstra K. , Scherphof GL , Meijer DK , Kaneda Y. Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes. J Drug Target 2007; 15: 75—82.

26.

Sato A. , Takagi M. , Shimamoto A. , Kawakami S. , Hashida M. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials 2007; 28: 1434—1442.

27.

Toklu HZ , Sehirli AO , Velioglu-Ogunc A. , Cetinel S. , Sener G. Acetaminophen-induced toxicity is prevented by beta-D-glucan treatment in mice. Eur J Pharmacol 2006; 543: 133—140.

28.

Tsai CL , Chang WT , Weng TI , Fang CC , Walson PD A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication . Clin Ther 2005; 27: 336—341.

29.

Sadowska AM , Manuel Ykb , De Backer WA Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 2007; 20: 9—22.

30.

Mulier B. , Rahman I. , Watchorn T. , Donaldson K. , MacNee W, Jeffery PK. Hydrogen peroxide-induced epithelial injury: the protective role of intracellular nonprotein thiols (NPSH). Eur Respir J 1998; 11: 384—391.

31.

Nagata K. , Iwasaki Y. , Yamada T. et al. Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respir Med 2007; 101: 800—807.

32.

Tsikas D. , Sandmann J. , Ikic M. , Fauler J. , Stichtenoth DO , Frolich JC Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J Chromatogr B Biomed Sci Appl 1998; 708: 55—60.

33.

Li YQ , Zhang ZX , Xu YJ et al. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms . Acta Pharmacol Sin 2006; 27: 339—346.

34.

Sury MD , Frese-Schaper M. , Muhlemann MK et al. Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med 2006; 41: 1372—1383.

35.

Suntres ZE , Lui EM Biochemical mechanism of metallothionein— carbon tetrachloride interaction in vitro. Biochem Pharmacol 1990; 39: 833—840.

36.

Gad SC , Weil CS Statistics for toxicoligists. New York: Raven, 1994.

37.

Suntres ZE Prophylaxis against lipopolysaccharide-induced liver injuries by lipoic acid in rats. Pharmacol Res 2003; 48: 585—591.

38.

Uchida K. Future of toxicology — lipid peroxidation in the future: from biomarker to etiology. Chem Res Toxicol 2007; 20: 3—5.

39.

Glantzounis GK , Yang W. , Koti RS , Mikhailidis DP , Seifalian AM , Davidson BR The role of thiols in liver ischemia-reperfusion injury. Curr Pharm Des 2006; 12: 2891—2901.

40.

Jurczuk M. , Moniuszko-Jakoniuk J. , Brzoska MM Involvement of some low-molecular thiols in the peroxidative mechanisms of lead and ethanol action on rat liver and kidney. Toxicology 2006; 219: 11—21.

41.

Patsoukis N. , Georgiou CD Determination of the thiol redox state of organisms: new oxidative stress indicators. Anal Bioanal Chem 2004; 378: 1783—1792.

42.

Atis S. , Nayci A. , Ozge A. , Comelekoglu U. , Gunes S. , Bagdatoglu O. N-Acetylcysteine protects the rats against phrenic nerve dysfunction in sepsis . Shock 2006; 25: 30—35.

43.

Caglikulekci M. , Dirlik M. , Pata C. et al. Effect of N-acetylcysteine on blood and tissue lipid peroxidation in lipopolysaccharide-induced obstructive jaundice . J Invest Surg 2006; 19: 175—184.

44.

Hsu BG , Yang FL , Lee RP , Peng TC , Harn HJ , Chen HI N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. J Biomed Sci 2004; 11: 152—162.

45.

Smyrniotis V. , Arkadopoulos N. , Kostopanagiotou G. et al. Attenuation of ischemic injury by N-acetylcysteine preconditioning of the liver. J Surg Res 2005; 129: 31—37.

46.

Fishbane S. , Durham JH , Marzo K. , Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004; 15: 251—260.

47.

Gillissen A. , Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998; 92: 609—623.

48.

Caglikulekci M. , Pata C. , Apa DD et al. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacol Res 2004; 49: 227—238.

49.

Chan EL , Murphy JT Reactive oxygen species mediate endotoxin-induced human dermal endothelial NF-kappaB activation. J Surg Res 2003; 111: 120—126.

50.

Lappas M. , Permezel M. , Rice GE N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 2003; 88: 1723—1729.

51.

Zafarullah M. , Li WQ , Sylvester J. , Ahmad M. Molecular mechanisms of N-acetylcysteine actions . Cell Mol Life Sci 2003; 60: 6—20.

52.

Iseri SO , Sener G. , Saglam B. , Gedik N. , Ercan F. , Yegen BC Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils . J Surg Res 2005; 126: 73—81.

53.

Stief TW The physiology and pharmacology of singlet oxygen. Med Hypotheses 2003; 60: 567—572.

54.

Vrba J. , Modriansky M. Oxidative burst of Kupffer cells: target for liver injury treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002; 146: 15—20.

55.

Lindner JR , Kahn ML , Coughlin SR et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 2000; 165: 6504—6510.

56.

Wiedermann FJ , Mayr AJ , Hobisch-Hagen P. , Fuchs D. , Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 2003; 23: 729—736.

57.

Suntres ZE , Shek PN Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats. Biochem Pharmacol 2000 ; 59: 1155—1161.

58.

Ohbayashi H.

Novel neutrophil elastase inhibitors as a treatment for neutrophil-predominant inflammatory lung diseases

IDrugs 2002; 5: 910—923.

59.

Wakayama F. , Fukuda I. , Suzuki Y. , Kondo N. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Ann Thorac Surg 2007; 83: 153—160.